CVG 2021 Seminar-2:Active Pharmaceutical Ingredient Synthesis
September 29 @ 5:30 pm to 6:30 pm
Speaker: Dr John Tobin, Acanthus Research Inc.
Seminar will be conducted online via Zoom @ 5:30 pm EDT and 3:30 MDT
An overview of the Drug Development Process will be presented based on observations from the perspective of a formulation scientist with 30+ years industry experience. The significance of interdisciplinary collaboration through out all stages of the process (from pre-clinical to post-commercialization) will be discussed.
Speaker: Dr. John Tobin
Dr. John Tobin is the co-founder of Acanthus Research Inc., a research-driven organization serving the pharmaceutical industry by providing quality reference standards and synthetic organic chemistry services.
John is a 25-year veteran of the pharmaceutical industry with extensive experience in analytical development for APIs and finished products.
John obtained his Ph.D. in Physical Organic Chemistry from the University of Toronto with research interests in reactive intermediates and enzyme reaction mechanisms. Dr. Tobin’s career has progressed in fields of medicinal chemistry (DuPont Merck Pharmaceuticals), diagnostic assay development (Ortho Clinical Diagnostics), analytical sciences in pharmaceutical development (GlaxoSmithKline), analytical services for a manufacturer of APIs (Torcan Chemicals), and analytical projects, including method development and validation, stability studies, and impurity identification, at a CRO supporting pharmaceutical, medical device and related industries (Exova). Currently, Dr. Tobin directs analytical development at Acanthus Research Inc. with focus on analytical certification of new molecules. John enjoys working with synthetic organic chemists addressing the challenges in the manufacture of new chemical entities.